Clinical Trial Update: ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer [NA]

View source ↗

Summary

A clinical trial evaluating ImmunoPET targeting Trop-2 in thyroid cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Tumor, Solid Tumor | NA | Status: TERMINATED